By Professor David Lawson Morris

Journal articles

Adams W; Morris DL, 1997, 'Cimetidine enhances tumor lymphocyte infiltration in human colorectal carcinoma.', Cancer, pp. 15 - 21

Dwerryhouse S; Cozzi PJ; Morris DL, 1997, 'Cryosurgery', Surgical Technology International, pp. 85 - 89

Dwerryhouse S; Morris DL, 1997, 'Cryotherapy for GI Cancers (editorial)', GI Cancer An International Journal, 2, pp. 85 - 88

Zhao J; Dwerryhouse S; Ross WB; Morris DL, 1997, 'Cryotherapy for hepatocellular carcinoma', Asian Journal of Surgery, 20

Alexandratos E; Butler SP; Glenn DW; Morris DL, 1997, 'Efficacy of lipiodol 1-131:response of treated & progression of untreated hepatocellular carcinoma within the same liver.', Asian Journal of Surgery, 20, pp. 264 - 265

King J; Capelhorn J; Ross WB; Morris DL, 1997, 'High serum CEA in patients with colorectal liver metastases is associated with poor cell mediated immunity (CMI), CMI is predictive of survival.', British Journal of Surgery, pp. 1382 - 1385

Reynolds JK; Akhter J; Adams W; Morris DL, 1997, 'Histamine content in colorectal cancer. Are there sufficient levels of histamine to affect lymphocyte function?', European Journal of Surgical Oncology, pp. 224 - 227

Huang Q; Morris DL; Dunckley H; Grennan D; Manolios N, 1997, 'Lack of linkage between antinuclear antibody or clinical features of systemic lupus erythematosus (SLE) and TCR-a/VB loci in families of subjects with SLE', Lupus, pp. 527 - 532

Maxwell-Armstrong C; Steele RJ; Amar S; Evans DJ; Morris DL; Foster GH; Hardcastle JD, 1997, 'Long term results of the insertion of the Angelchik prosthesis for gastro-oesophageal reflux', British Journal of Surgery, pp. 862 - 864

Dwerryhouse S; Morris DL, 1997, 'Non-cytoxic control of colorectal cancer (review)', Journal of the Royal College of Surgeons of Edinburgh, pp. 147 - 153

Morris DL; Zhao J; Clingan PR, 1997, 'Previous intravenous chemotherapy does not alter response rate or survival time of patients with hepatic metastases from colroectal cancer treated by hepatic artery chemotherapy.', British Journal of Surgery, pp. 796 - 797

Cozzi PJ; Lynch WJ; Collins S; Vonthethoff L; Morris DL, 1997, 'Renal Cryotherapy in a Sheep Model; A Feasability Study', The Journal of Urology, pp. 710 - 712, http://dx.doi.org/10.1097/00005392-199702000-00093

Cozzi PJ; Lynch W; Collins SL; Vonthethoff LW; Morris DL, 1997, 'Renal cryotherapy in a sheep model; a feasibility study.', Journal of Urology, 157, pp. 710 - 712

Wang X; Chen X; Akhter J; Morris DL, 1997, 'The invitro effect of Vitamin D3 analogue EB1089 on a human prostate cancer cell line (PC-3).', British Journal of Urology, pp. 260 - 262

Fenton-Lee D; Ross WB; Clingan PR; Phadke K; Morris DL, 1997, 'The role of portal vein chemotherapy following failure of previous treatment for advanced colorectal hepatic metastases', British Journal of Surgery, pp. 205 - 206

Akhter J; Chen X; Bowrey P; Bolton E; Morris DL, 1997, 'Vitamin D3 analogue EB1089 inhibits growth of subcutaneous xenografts of the human colon cancer cell line LoVo in a nude mouse model.', Diseases of the Colon and Rectum, pp. 317 - 321

Biankin AV; Geiser J; Morris R; Morris DL, 1996, 'Novel use of patient activated pump for ambulant regional chemotherapy', Regional Cancer Treatment, 9, pp. 128 - 130

Englert M; Morris D; March L, 1996, 'Silicone? Silica? Scleroderma. A need to look further?', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 26, pp. 858 - 858, http://dx.doi.org/10.1111/j.1445-5994.1996.tb00645.x

Morris DL, 1996, 'A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma', Cancer, 77, pp. 1956 - 1956a, http://dx.doi.org/10.1002/(sici)1097-0142(19960501)77:9<1956::aid-cncr28>3.3.co;2-i

Morris DL; Goldberg RM; Wieand HS; Krook JE; Schutt AJ; Veeder MH; Maillaird JA; Dalton RJ, 1996, 'A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma [1]', Cancer, 77, pp. 1956, http://dx.doi.org/10.1002/(sici)1097-0142(19960501)77:9<1956::aid-cncr28>3.3.co;2-i

Morris DL; Ross WB, 1996, 'Australian experience of cryoablation of liver tumors: Metastases', Surgical Oncology Clinics of North America, 5, pp. 391 - 397, http://dx.doi.org/10.1016/s1055-3207(18)30389-2

Adams WJ; Morris DL, 1996, 'Carcinoembryonic antigen in the evaluation of therapy of primary and metastatic colorectal cancer', Australian and New Zealand Journal of Surgery, 66, pp. 515 - 519, http://dx.doi.org/10.1111/j.1445-2197.1996.tb00800.x

Morris W, 1996, 'Cimetidine and colorectal cancer', Diseases of the Colon and Rectum, 39, pp. 115

Huang QR; Morris D; Manolios N, 1996, 'Evaluation of the BCL-2 gene locus as a susceptibility locus linked to the clinical expression of systemic lupus erythematosus (SLE)', Rheumatology International, 16, pp. 121 - 124, http://dx.doi.org/10.1007/BF01409984

, 1996, 'Hepatic Cryotherapy for Cancer: A Review and Critique', HPB Surgery, 9, pp. 118 - 120, http://dx.doi.org/10.1155/1996/52565

Hellstrand K; Brune M; Mellqvist UH; Maredi P; Morris DL, 1996, 'Histamine, cimetidine and colorectal cancer [1]', Nature Medicine, 2, pp. 364 - 365, http://dx.doi.org/10.1038/nm0496-364a

Cozzi PJ; Mccall JL; Jorgensen JO; Morris DL, 1996, 'Laparoscopic vs Open Ultrasound of the Liver: An in vitro Study', HPB Surgery, 10, pp. 87 - 89, http://dx.doi.org/10.1155/1996/71637

Ross WB; Morris DL; Clingan PR, 1996, 'Major upper gastrointestinal haemorrhage associated with hepatic arterial chemoperfusion', Australian and New Zealand Journal of Surgery, 66, pp. 816 - 819, http://dx.doi.org/10.1111/j.1445-2197.1996.tb00756.x

Englert H; Morris D; March L, 1996, 'Scleroderma and silicone gel breast prostheses - The Sydney study revisited', Australian and New Zealand Journal of Medicine, 26, pp. 349 - 355, http://dx.doi.org/10.1111/j.1445-5994.1996.tb01921.x

Fenton-Lee D; Morris DL, 1996, 'The Management of Hydatid Disease of the Liver: Part 1', Tropical Doctor, 26, pp. 173 - 176, http://dx.doi.org/10.1177/004947559602600413

Cozzi PJ; Morris DL, 1996, 'Two Cases of Spontaneous Liver Rupture and Literature Review', HPB Surgery, 9, pp. 257 - 260, http://dx.doi.org/10.1155/1996/24016

Akhter J; Goerdel M; Morris DL, 1996, 'A vitamin D3 analogue (EB1089) inhibits in vitro cellular proliferation of human colon cancer cells', British Journal of Surgery, pp. 229 - 230

Cozzi PJ; Morris DL, 1996, 'Case reports : two cases of spontaneous liver rupture and literature review', HPB Surgery, pp. 257 - 260

Adams W; Morris DL, 1996, 'CEA in the evaluation of therapy of primary and metastatic colorectal cancer', Australian and New Zealand Journal of Surgery, pp. 515 - 519

Ross WB; Song YQ; Morris DL, 1996, 'Computer image analysis and measurement of liver tumour volume from computerised tomography slices', Surgical Research Communications, 18, pp. 167 - 170

Cozzi PJ; Lawson JS; Lynch W; Morris DL, 1996, 'Critical temperature for in vivo cryoablation of human prostate cancer in a xenograft movel', British Journal of Urology, pp. 89 - 92

Morris DL; Ross WB; Iqbal J; Mccall JL; King JA; Clingan PR, 1996, 'Cryoablation of hepatic malignancy:an evaluation of tumor marker data and survival in 110 patients', GI Cancer An International Journal, 1, pp. 247 - 251

Romani R; Howes LG; Morris DL, 1996, 'Dose dependent in vivo inhibition of human colorectal cancer (LoVo) by the gastrin receptor antagonist C1-988', Clinical and Experimental Pharmacology and Physiology, pp. 438 - 440

Romani R; Howes LG; Morris DL, 1996, 'Gastrin receptor antagonist, CI-988 inhibits basal growth of a human colon cancel cell line both in vivo and in vitro', Australian and New Zealand Journal of Surgery, pp. 235 - 237

Romani R; Howes LG; Morris DL, 1996, 'Gastrin receptor antogonist C1-988 inhibits growth of human colon cancer invivo and in vitro', Australian and New Zealand Journal of Surgery, pp. 235 - 237

Preketes A; King JA; Bolton E; Clingan PR; Kwang Y; Morris DL, 1996, 'Immunological activity and serum CEA levels following oral administration of a muramyl dipeptide (GMDP) to patients with advanced colorectal cancer', Surgical Research Communications, 18, pp. 137 - 146

Cozzi PJ; Lynch W; Vonthethoff LW; Robson N; Lumley T; Morris DL, 1996, 'In vitro and in vivo assessment of urethral warming catheters for transperineal cryoablation of prostate carcinoma', British Journal of Urology, pp. 589 - 595

Reynolds JK; Akhter J; Morris DL, 1996, 'In vitro effect of histamine and histamine H1 & H2 receptor antagonists on cellular proliferation of human malignant melanoma cell lines', Melanoma Research, pp. 95 - 99

Mccall JL; Jorgensen J; Morris DL, 1996, 'Laparoscopic hepatic cryotherapy:a study of safety in rabbits', Surgical Laparoscopy Endoscopy and Percutaneous Techniques, pp. 29 - 31

Ross WB; Morris DL; Clingan PR, 1996, 'Major upper gastrointestinal haemorrhage associated with hepatic arterial chemoperfusion', Australian and New Zealand Journal of Surgery, pp. 814 - 817

Belov L; Akhter J; Meher-Homji V; Nicholas S; Miller L; Morris DL, 1996, 'Monoclonal antibody 2C1 does not recognise the CCK-B gastrin receptor', Surgical Research Communications, 18, pp. 183 - 195

Dasappa V; Ross WB; King JA; King DW; Clingan PR; Morris DL, 1996, 'Primary resection and synchronous regional hepatic chemotherapy or cryotherapy for colorectal cancer with liver metastases', International Journal of Colorectal Disease, 11, pp. 38 - 41

Preketes A; Boyd SJ; Cooper DA; Mckay E; Smart RC; Quinn RJ; Ross WB; Clingan PR; Mccall JL; Butler SP; Glenn DR; Clark E; Morris DL, 1996, 'Pulmonary toxicity following lipiodol I-131 treatment for liver tumours', Regional Cancer Treatment, pp. 21 - 26

Lawson JS; Adams W; Morris DL, 1996, 'Ranitidine & Cimetidine differ in their in vitro and in vivo effects on human colonic cancer growth', British Journal of Cancer, pp. 872 - 876

Wing Kit Ng ; Robilliard JF; Morris DL, 1995, 'Disease free survival beyond 1 year for advanced carcinoma of the gall bladder after cholecystectomy, cryotherapy of the liver bed and lymphatic dissection followed by hepatic artery cytotoxic infusion therapy: A case report', Regional Cancer Treatment, 8, pp. 166 - 167

Back to profile page